Preventing Surgical Site Infections after Bariatric Surgery: Value of Perioperative Antibiotic Regimens

Teena Chopra; Jing J Zhao; George Alangaden; Michael H Wood; Keith S Kaye


Expert Rev Pharmacoeconomics Outcomes Res. 2010;10(3):317-328. 

In This Article

Five-year View

Over the next 5 years, we anticipate that the population of patients undergoing bariatric surgery will grow immensely. Unfortunately, SSI pathogens are becoming more resistant to standard antimicrobials. In particular, the continuing spread of community-acquired MRSA and extended-spectrum β-lactamase-producing Gram-negative bacilli will make the delivery of effective antimicrobial prophylaxis more challenging, particularly in the obese population. Public reporting of infection rates and decreased insurance reimbursements for hospital-acquired infections, such as SSIs, might have a profound effect on the bariatric surgery population, as these patients are generally at 'high risk' for SSIs and have a relatively high frequency of comorbid conditions, increasing their risk for SSIs.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.